DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mubritinib
Mubritinib
Nick-Thomas.Pdf
Related Kinases (VRK) Bound to Small-Molecule Inhibitors Identifies Different P-Loop Conformations
Modifications to the Harmonized Tariff Schedule of the United States To
Targeting the Function of the HER2 Oncogene in Human Cancer Therapeutics
Elife-55845-Figures.Pdf
A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre- Clinical Discoveries
(INN) for Pharmaceutical Substances" WHO/EMP/RHT/TSN/2018.1
I Regulations
Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma
Effectiveness of EGFR/HER2-Targeted Drugs Is Influenced by The
SUPPLEMENTARY APPENDIX Erlotinib Synergizes with the Poly(ADP-Ribose) Glycohydrolase Inhibitor Ethacridine in Acute Myeloid Leukemia Cells
Stembook 2018.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2016/0022680 A1 SUN Et Al
Targeting the 'Oligomerization Region'of the Epidermal Growth
Effective Combinatorial Immunotherapy for Penile Squamous Cell Carcinoma
Signalling Downstream of PI3 Kinase in Mammary Epithelium: a Play in 3 Akts Julie a Wickenden and Christine J Watson*
(12) Patent Application Publication (10) Pub. No.: US 2015/0080239 A1 RHODES Et Al
Epidermal Growth Factor Receptor; Erbb-1; HER1
Top View
As an Inhibitor of KSHV Driven Primary Effusion Lymphoma Via Disruption of Mitochondrial OXPHOS Metabolism
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Comparative Assessment of Protein Kinase Inhibitors in Public Databases and in PKIDB
Current Issues – Problems & Solutions
Riport Letöltése
Leukemia Stem Cell-Bone Marrow Microenvironment Interplay in Acute
Download Product Insert (PDF)
(12) Patent Application Publication (10) Pub. No.: US 2015/0322155A1 Zhao (43) Pub
Selleckchem Kinase Inhibitor Library 96Well Format
This Thesis Has Been Submitted in Fulfilment of the Requirements for a Postgraduate Degree (E.G
Pharmacological Profiling of Kinase Dependency in Cell Lines Across Triple-Negative Breast Cancer Subtypes
JAK/STAT Signaling
Comparative Analysis of the Kinase Selectivity Profile of Masitinib and Its Competitors in Clinical Trials Summary
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/Mtor, Aurora Kinase and EZH2 Inhibitors
Mitochondrial Metabolism As a Target for Acute Myeloid Leukemia Treatment Svetlana B
Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 As a Target for Neuroblastoma Tumor-Initiating Cells
Oncompass Report NÉV Anonymous a Realtime Oncology Molecular Treatment Calculator Számításaival
Reciprocal Expression of INSM1 and YAP1 Defines Subgroups in Small Cell Lung Cancer
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Mitochondrial Determinants of Response and Resistance to Venetoclax Plus Cytarabine
Supplementary Materials
INN Working Document 19.461 17/09/2019
Tusc2 Therapies Tusc2 Therapien Therapies De Tusc2
Genetic Landscape of Electron Transport Chain Complex I
Identification of a Novel Toxicophore in Anti-Cancer Chemotherapeutics That
New Therapeutic Approaches for Acute Myeloid Leukaemia